As it tries to determine how to regulate CBD, the FDA is asking for comments about CBD-related health and safety, quality control, product labeling, and other issues.
The post The FDA Is About to Deal With CBD—and Wants to Hear From You appeared first on Leafly.
Read More: The FDA Is About to Deal With CBD—and Wants to Hear From You
Comments are closed, but trackbacks and pingbacks are open.